newsfilter
← Latest News
ACCESS Newswire·

Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Company To Host an Investor Conference Call on Tuesday, November 2, 2021 at 8:00 AM EDT Dosing completed in part 1a of phase 2a study of PRS-060/AZD1402 Dosing to begin this quarter in phase 2 study of cinrebafusp alfa Received regulatory approval fr